Generating the Evidence Base for Convalescent Plasma Use for a New Infectious Disease
Author:
Publisher
Springer Berlin Heidelberg
Link
https://link.springer.com/content/pdf/10.1007/82_2024_275
Reference56 articles.
1. Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P (2020) Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ 371:m3939. https://doi.org/10.1136/bmj.m3939
2. Bandopadhyay P, D’Rozario R, Lahiri A et al (2021) Nature and dimensions of systemic hyperinflammation and its attenuation by convalescent plasma in severe COVID-19. J Infect Dis 224(4):565–574. https://doi.org/10.1093/infdis/jiab010
3. Bégin P, Callum J, Jamula E et al (2021) Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat Med. https://doi.org/10.1038/s41591-021-01488-2
4. Boulware DR, Pullen MF, Bangdiwala AS et al (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 383(6):517–525. https://doi.org/10.1056/NEJMoa2016638
5. Bramante CT, Huling JD, Tignanelli CJ et al (2022) Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19. N Engl J Med 387(7):599–610. https://doi.org/10.1056/NEJMoa2201662
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3